"Some day this disease will be considered a treatable nuisance"
-- Dr. Vescio from Cedars Sinai

USA Support Groups

Events Calendars



Home Page

Awareness Building

Amyloidosis Info

TTR & Familial

Important Clinical Trials

Upcoming Events

About Us

Contact Us

Patient & Care Giver Resources

Awareness Items & Donations

Fundraising Events

AMY Blogs

Patient's Day

Survivor Stories

In Memoriam

Support Groups

**TTR & Familial**

Arizona/Southwest
(Phoenix)


Carolinas (Charlotte)

Florida (Jacksonville)

Florida (Miami)

Florida (Tampa)

Georgia/Alabama

Indianapolis/Chicago

Kansas City

Louisiana

Maryland (Baltimore/D.C.)

Maryland (Hagerstown)

Massachusetts (Boston)

Michigan/Ohio

Nevada (Las Vegas)

New York City

New York (Rochester)

Ohio/PA

Pacific Northwest (Portland)

Philadelphia

Rocky Mountains (Denver)

Southern California (L.A.)

Texas (Dallas)

Minnesota/Upper Midwest

Utah


UK SUPPORT GROUP WEB SITE


International Amyloidosis Centers
Center for the Study of Familial Amyloidosis
(Rio de Janeiro, Brazil) –
Center for the Study & Cure of Systemic Amyloidosis
(Pavia, Italy) –
Germany
(Heidelberg) –
Groningen Unit for Amyloidosis Research & Development
(The Netherlands) –
National Centre for Amyloidosis
(London, U.K.) –
Princess Alexandra Hospital
(Brisbane, Australia) –
Spain
(Barcelona) –
Westmead Hospital
(Sydney, Australia) –
Kumamoto University Hospital
(Kumamoto, Japan) –
Princess Margaret Cancer Centre
(Toronto, Canada) –


Support Group Tips

Clinical Trial

Eastern Cooperative Oncology Group:

E2A01 Trial for Patients With Amyloidosis

You can learn more about this trial by viewing a short informational video featuring Dr. Morie Gertz, the study chair for this trial:

E2A01 Real Media Video
E2A01 Windows Media Video

Click here for a list of institutions participating in this trial

This trial is looking at whether Amifostine can help make transplants safer for patients with amyloidosis.

If you are placed in the study you will undergo a procedure called stem cell mobilization where cells will be collected from your bloodstream to use in the subsequent transplant. You will then receive amifostine for two days followed by melphalan and one day later your stem cells will be returned.

Patients on this study will be followed for up to ten years to assess the long-term effects of the study treatments.



Amyloidosis Support Groups
AmyloidosisSupport.org
1-866-404-7539 TOLL FREE USA